Shanghai, China

Yuxun Wang



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: **Innovative Contributions of Yuxun Wang in Pharmaceutical Science**

Introduction

Yuxun Wang is a notable inventor based in Shanghai, China, recognized for his contributions to pharmaceutical innovations. He holds a patent that focuses on a specific class of chemical compounds with significant therapeutic potential. His work is exemplified by the development of a benzazepine derivative, which holds promise in treating various diseases mediated by the TLR family.

Latest Patents

Yuxun Wang's patent titled "Benzazepine derivative, preparation method, pharmaceutical composition and use thereof" showcases a compound that is effective in regulating the TLR family and its associated signaling pathways. The derivatives disclosed in the patent are noted for their ability to manage TLR8, a target implicated in numerous diseases, including cancers, autoimmune disorders, infections, inflammations, and transplant rejections. This innovative discovery highlights the potential applications of these compounds in the pharmaceutical industry.

Career Highlights

Yuxun Wang is currently affiliated with Shanghai De Novo Pharmatech Co., Ltd., where he continues to advance research in the field of pharmacology. His work has opened new avenues for treating diseases through targeted molecular therapies. The single patent under his name is a testament to his commitment to innovation and progress in medical science.

Collaborations

Throughout his career, Yuxun Wang has collaborated with colleagues such as Daxin Gao and Shoujun Chen. These collaborations foster a creative environment that enhances research and development processes, aiming to bring forth innovative solutions in healthcare.

Conclusion

Yuxun Wang's contributions in the pharmaceutical realm, particularly through the development of the benzazepine derivative, illustrate the importance of innovation in combating complex medical challenges. His ongoing work at Shanghai De Novo Pharmatech Co., Ltd. positions him as a key figure in pharmaceutical research, promising advancements in treatment methodologies that may significantly impact patient care and disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…